Mohamed Sorror, M.D., M.Sc.

Mohamed Sorror M.D., M.Sc.
faculty member

Mohamed Sorror, M.D., M.Sc.

Associate Member
Clinical Research Division, Fred Hutch

Fax: 206.667.5899
Mailstop: D5-280

Dr. Mohamed Sorror’s research is dedicated to improving the care of older, frailer or medically complicated patients with blood cancers. While most people with blood cancers are seniors, studies of new treatments for these diseases routinely exclude them. To solve this problem, Dr. Sorror is gathering evidence and developing decision-making tools to guide the choice of the best treatment for these patients. He leads a large, multi-center, randomized trial testing novel interventions, such as palliative care and dedicated management of individual comorbidities, for patients receiving stem cell transplants to treat blood cancers. Through both clinical and population-based studies, Dr. Sorror aims to optimize the benefits of health care to patients and to society. For example, he is testing, developing and validating methods and tools to predict patient outcomes on treatment, including survival, toxicity and quality of life. He is learning patients’ experiences, preferences and values for cancer treatment. And his trials are generating evidence of which interventions work best for which types of patients and under what circumstances. Notably, he and colleagues developed the first scoring system, now used worldwide, for predicting the risks a blood stem cell transplant poses for a particular patient.

Other Appointments & Affiliations

Associate Professor of Medicine
University of Washington

Education

M.D., Medicine, Assiut University, Assiut, Egypt, 1993

M.Sc., Internal Medicine, Assiut University, Assiut, Egypt, 1998

Current Projects

Impact of Comorbidities and Age on Outcomes of Allogeneic Transplantation

Assessment of biomarkers for prognostic evaluation of transplant outcomes

Predictors of treatment-related mortality after autologous transplantation

Clinical and biological understanding of the roles of comorbidities in development of post-transplant complications

Tools and Information to Guide Choice of Therapies is Older & Medically Infirm Patients with AML

spotlight

“For older patients, the time remaining is extremely precious — and their focus is on those fine details of enjoying life, on the time they spend with a partner, with loved ones.”

—Dr. Mohamed Sorror

Find A Clinical Trial

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email media@fredhutch.org or call 206.667.2210